- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07437144
Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Breast Cancer Patients With Insomnia
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: YUN TZU HUANG, R.N., Ph.D. Candidate
- Phone Number: 11335 +886-4-22052121
- Email: monkey3618@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Breast cancer patients aged ≥20 years diagnosed with 0-III cancer, without any signs of metastasis or recurrence
- Cases who have completed surgery, targeted therapy, chemotherapy, or radiotherapy at least 3 months ago.
- Cases who have started taking anti-hormone inhibitors and traditional Chinese medicine for 3 months.
- Pittsburgh Sleep Quality Scale (CPSQI) score ≥5.
- Cases who are willing to participate and complete the consent form.
Exclusion Criteria:
- Patients with other cancers.
- Illiterate
- Patients with physical disabilities or inability to perform physical activities.
- Patients diagnosed with mental illness by a physician.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Shangshou Daoyin Method and Routine Care
The experimental group received instruction in the Shangshou Daoyin Method Exercise and routine care for a total of 20 minutes.
Patients were then instructed to perform the Shangshou Guiding Exercise at home at least three times a week for 20 minutes each time, for 12 weeks.
|
During the trial, the intervention involved performing Shangshou Daoyin Method exercises at least three times a week,while the control group received only routine care for 12 weeks.
During the intervention, daily reminders were sent via Line (to wear an activity tracker 30 minutes before bedtime to monitor sleep time and efficiency, and to review the sleep log every morning), and weekly reminders were sent to submit sleep time, efficiency, and seven-day sleep log results.
Researchers provided individualized routine care and administered activity recorders, along with paper logbooks.
Participants were instructed on how to fill out the logbook and use the activity recorder.
After joining the official Line group, participants were instructed on how to use Line.
In addition to daily reminders and support via Line, participants were asked to wear the activity recorder 30 minutes before bedtime and to regularly submit data via Line.
|
|
Placebo Comparator: Routine Care
|
Researchers provided individualized routine care and administered activity recorders, along with paper logbooks.
Participants were instructed on how to fill out the logbook and use the activity recorder.
After joining the official Line group, participants were instructed on how to use Line.
In addition to daily reminders and support via Line, participants were asked to wear the activity recorder 30 minutes before bedtime and to regularly submit data via Line.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chinese version of the Pittsburgh Sleep Quality Index (CPSQI)
Time Frame: Baseline (Pre-test), Week 4, Week 8, and Week 12.
|
Primarily measures the subject's sleep quality over the past month. The questionnaire includes seven dimensions: subjective sleep quality, sleep latency, total sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Scores for the seven dimensions range from 0 to 3, with a total score from 0 to 21. Higher scores indicate poorer sleep quality. A total score of 5 or less indicates good sleep quality, while a total score greater than 5 indicates poor sleep quality. |
Baseline (Pre-test), Week 4, Week 8, and Week 12.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire(EORTC QLQ-C30)
Time Frame: Baseline (Pre-test), Week 4, Week 8, and Week 12.
|
The primary measure was the degree of distress experienced by participants due to cancer-related issues.
The questionnaire consisted of 30 questions across 5 functional dimensions, 9 symptom dimensions, and 1 overall quality of life dimension, for a total of 15 dimensions.
The total score ranged from 0 to 100.
Higher scores on the functional and overall quality of life dimensions indicated a better quality of life; higher scores on the symptom dimensions indicated more severe symptom problems.
|
Baseline (Pre-test), Week 4, Week 8, and Week 12.
|
|
Body Constitution Questionnaire(BCQ)
Time Frame: Baseline (Pre-test), Week 12.
|
The primary objective was to measure the occurrence of subjective physical symptoms reported by the subjects over the past month.
The scale consisted of three independent body mass scales: a 16-item phlegm-dampness stagnation scale, a 19-item yin-blood deficiency scale, and a 19-item yang-qi deficiency scale.
Since some items were shared across the three scales, the total number of items was 44.
A five-point Likert scale was used for scoring; higher scores indicated a stronger affinity for that constitution type.
A total score of ≥27 on the phlegm-dampness stagnation scale indicated a phlegm-dampness stagnation constitution; a total score of ≥30 on the yin-blood deficiency scale indicated a yin-blood deficiency constitution; and a total score of ≥31 on the yang-qi deficiency scale indicated a yang-qi deficiency constitution.
If the scores on all three scales did not reach the cut-point, the subject was classified as having a balanced constitution.
|
Baseline (Pre-test), Week 12.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CMUH114-REC2-225
- DMR-115-140 (Other Grant/Funding Number: ChinaMUH)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer Patients Diagnosed With Stage 0-III
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Stage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | Stage III Breast Cancer | Stage 0 Breast Carcinoma | Stage II Breast Carcinoma | Stage III Breast Carcinoma | Hormone-receptor-positive...United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8United States
-
Mayo ClinicRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterBreast Cancer Research FoundationCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Columbia UniversityActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Nevada Cancer InstituteVonsUnknownEarly Stage Breast Cancer (Stage 0-III)United States
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage 0United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...Active, not recruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage 0United States, Guam, Puerto Rico
Clinical Trials on Shangshou Daoyin Method
-
Tri-Service General HospitalCompleted
-
Shanghai University of Traditional Chinese MedicineShanghai Mental Health CenterRecruitingAnxiety Symptom | Depression SymptomChina
-
Northeast Normal UniversityCompleted
-
Affiliated Hospital of Liaoning University of Traditional...Xiyuan Hospital of China Academy of Chinese Medical Sciences; The First Affiliated...Not yet recruiting
-
Shanghai University of Traditional Chinese MedicineShanghai Mental Health CenterCompleted
-
Henan University of Traditional Chinese MedicineRecruiting
-
Henan University of Traditional Chinese MedicineUnknownPulmonary Disease, Chronic Obstructive
-
University of North Carolina, Chapel HillWithdrawn
-
Firat UniversityCompletedPain | Child Development | Nursing CareTurkey
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletedNursing Student | Virtual Patient | Debriefing MethodTurkey